Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Rituximab Vasculitis Maintenance Study (RITAZAREM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Cambridge University Hospitals NHS Foundation Trust
Sponsor:
Collaborators:
Arthritis Research UK
Roche Pharma AG
Genentech, Inc.
University of Pennsylvania
Information provided by (Responsible Party):
David Jayne, Cambridge University Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01697267
First received: August 31, 2012
Last updated: September 11, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)